(238c) A Systematic Model Development Framework for Batch Crystallization Using Iterative Model-Based Experimental Design Approach
AIChE Annual Meeting
2023
2023 AIChE Annual Meeting
Separations Division
Crystallization and Precipitation of Pharmaceutical and Biological Molecules
Wednesday, November 8, 2023 - 1:09pm to 1:27pm
The focus of this work is based on a two-tier strategy with optimal experimental design for sequential model discrimination and parameter precision. The experimental design strategy is performed iteratively based on a previously available experimental data set(s) to design a new experiment based on a performance criterion. The new experiment is executed to collect experimental observations that are appended to the experimental data set and evaluated for the targeted objectives. Thus, the iterative model development approach (IMED) iterates design, execution and evaluation steps automatically to determine a best mechanistic model and corresponding parameters. The proposed workflow is demonstrated for modeling an industrial pharmaceutical compound from Takeda pharmaceutical International Co.
The modeling of batch cooling crystallization of the compound is carried out with a carefully designed DoE for initial parameter estimation considering seeded experiments with varying seed loads, initial supersaturation and linear cooling ramps. Model database for initial model identification and discrimination steps consist of various nucleation, growth, agglomeration mechanisms and corresponding mathematical expressions. D-optimality criterion applied for model refinement to find optimally informative experiments is successful in minimizing uncertainties of the estimated crystallization model parameters. Based on the obtained results, it can be inferred that IMED proves to be a promising tool for discrimination of many rival models and further refinement of model parameters. This two-tier model development approach presented can serve as a generic framework for batch crystallization processes.
Acknowledgement
Financial Support from Takeda Pharmaceuticals International Co. is gratefully acknowledged.
References
- Szilagyi, A. Eren, J.L. Quon, C.D. Papageorgiou, Z.K. Nagy, 2020, Application of model-free and model-based Quality-by-Control (QbC) for the efficient design of pharmaceutical crystallization processes, Cryst. Growth & Des., 20, 6, 3979â3996.
- H. Chung, D. L., Ma., R. D., Braatz, 2000, Optimal model-based experimental design in batch crystallization. Chemometrics and Intelligent Laboratory Systems, 50(1), 83-90.
- H. Chen, S., Bermingham, A.H., Neumann, H.J. Kramer, S.P., Asprey, 2004, On the design of optimally informative experiments for dynamic crystallization process modeling, Industrial & engineering chemistry research, 43(16), 4889-4902.
- Pal, B. Szilagyi, Burcham, C.L., D.J. Jarmer, Z.K. Nagy, 2021, Iterative modelâbased experimental design for spherical agglomeration processes. AIChE Journal, 67(5), e17178.